Results
Italian Medicines Agency
Italian Medicines Agency
03/13/2026 | News release | Distributed by Public on 03/13/2026 06:05
Comunicazione AIFA su Barbesaclone 100 mg
Nuove e importanti informazioni relative alla produzione e alla distribuzione del medicinale a denominazione generica Barbesaclone 100mg compresse rivestite - PROROGA SCADENZA.
Pubblicato il: 13 marzo 2026
Italian Medicines Agency published this content on March 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 13, 2026 at 12:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]